DCI Center for Prostate & Urologic Cancers

A multidisciplinary center within @DukeCancer focused on patient care and cutting-edge clinical, translational and population research.

[Duke Clinical and Translational Science Institute @Duke_CTSI]

We proudly present our 2022 impact report, highlighting valuable contributions to advancing science, research, and health equity and the great work we have achieved with our partners.

CTSI Translational Impact: Advancing Equity

Read the report ➡️ https://t.co/6qQiQpIJNH

[DCI Center for Prostate & Urologic Cancers @DukeGUCancer]

Our own @DukeBiostats @DukeCancer professor Susan Halabi, PhD, was honored by @uabSOPH this week for career achievement. Notably, she was the 1st statistician ever to be named an @ASCO fellow!

[Duke University School of Medicine @DukeMedSchool]

Susan Halabi, PhD, professor of biostatistics and bioinformatics (B&B), received the 21st annual Janet L. Norwood Award for Outstanding Achievement by a Woman in Statistical Sciences from @uabSOPH. Halabi is known for her research on #prostatecancer.
https://t.co/HYGC8NuQ3Z

[DCI Center for Prostate & Urologic Cancers @DukeGUCancer]

1 in 8 men will be diagnosed with #prostatecancer in their lifetime. If caught early, most can be cured. Men over 50, talk to your doc ab #prostate #cancer #screening – a simple blood test could save your life. @DukeCancer

[Duke Oncology Pharmacy Programs @DukeOncRx]

Another great addition to the Duke Oncology Pharmacy team! Welcome Andrea who will be working in our GU Medical Oncology Clinic! @Daniel_J_George @DukeCancer

[DCI Center for Prostate & Urologic Cancers @DukeGUCancer]

Incredible work by @DukeFellows very best @hannahdzmd with mentorship by @AarmstrongDuke highlighting the importance of the patient voice in prostate cancer trials! 👏🏻👏🏻👏🏻

[Andrew Armstrong @AarmstrongDuke]

Elevating the patient voice in mHSPC trials: see our JCO editorial out today in @JCO_ASCO @DukeGUCancer https://t.co/V1d7f9N98o

[Mary Weinstein Dunn @MaryWDunn]

Save the date! Registration is open! @UNCurology @UNC_Lineberger @UNCUroOnc @DukeUrology @DukeCancer @DukeGUCancer #bladdercancer #blcsm #walktoendbladdercancer

[Julie Rasmussen @JulieRasRN]

@DukeGUCancer is hiring a clinical research nurse coordinator. This team is where I got my start in clinical research over 8 years ago and is a great place to learn! @UNCSON @DukeU_NrsngSchl #NurseTwitter https://t.co/J04LM49WgE

[The PCCTC @ThePCCTC]

Study by esteemed PCCTC investigator @Daniel_J_George (@DukeGUCancer) and colleagues finds black men with chemotherapy-naïve metastatic prostate cancer initiating novel hormonal therapy may have better outcomes than similarly treated white men https://t.co/mrCiWkcV5w

[Kidney Cancer @KidneyCancer]

Register now for the @DukeGUCancer patient education symposium on GU cancers on Friday. Watch for the #kidneycancer session featuring @Daniel_J_George @WilliamKimMD and Dr. Stacey Lisi. https://t.co/KdMVegf1jy

[The PCCTC @ThePCCTC]

PCCTC investigator @AarmstrongDuke (@DukeGUCancer, @DukeCancer) discusses precision medicine approaches in advanced prostate cancer via @mydocwire https://t.co/3PL6VI0mSU

[Andrew Armstrong @AarmstrongDuke]

Join us for spring break at Disney! The Duke Urologic Assembly 2022 is on! Both in person and hybrid options are available with a great team of expert speakers for this CME event focused on precision urologic oncology and urology: @DukeGUCancer

https://t.co/4pFMmzTJms

[Tian Zhang, MD, MHS, FASCO (@tiansterzhangmd.bsky) @TiansterZhang]

A culture of mentoring fosters creativity & academic productivity. So glad to highlight our group w/ @Daniel_J_George @AarmstrongDuke @MRHarrisonMD & amazing trainees @TheRealJasonZhu @_joycehwang @LandonBrownMD @ChesterKao1 @hannahdzmd @MattLabsMD I was fortunate to work with!

[Sumanta K. Pal, MD, FASCO @montypal]

Hard to believe @OncHahn is a fellow; during his time at @huntsmancancer & now @MDAndersonNews he has been incredibly prolific. No surprise with mentors like @neerajaiims. Terrific paper w @Daniel_J_George @DukeGUCancer. Great insight & graphics that are sure to appear at #GU22.

[Andrew Armstrong @AarmstrongDuke]

Great PROPHECY team and story summarizing our latest findings:

https://t.co/YTRHLvxffD @DukeGUCancer @DukeCancer @hopkinskimmel @WCMCPathology @ThePCCTC

[Checkpoint Now Podcast Series @CheckpointNowMD]

We are back after a break. This time with an episode showcasing resident perspective on managing irAEs. Join hosts @afreenshariffmd @TiansterZhang as they d/w @IMResidencyDuke physicians @nathanhirshy @MFerreiraMD Dr. Harsh Patolia to learn more.
👉 https://t.co/XfGLXUAnlQ

[Judd Moul @JuddMoul]

One week to go until #AUA21. Looking forward to debate with @LiMingSu1 on pros and cons of maintaining open RRP experience for urology residency training. Friday September 10th live during plenary session. @DukeUrology @DukeCancer @DukeGUCancer

[OncLive SOSS @OncLiveSOSS]

.@TiansterZhang, of @DukeCancer, discussed key considerations regarding frontline immunotherapy-based combinations in RCC and recent data from pivotal trials examining their use #kcsm https://t.co/1YMYq4g6jX

[Tian Zhang, MD, MHS, FASCO (@tiansterzhangmd.bsky) @TiansterZhang]

Congratulations @TracyLRoseMD @MattMilowsky on your publication! Was great to enroll & treat patients on the trial @DukeGUCancer. More data for neoadjuvant IO-chemo for muscle invasive #bladdercancer. @BladderCancerUS @Daniel_J_George @DrChrisHoimes @AarmstrongDuke 👏👏

[Tian Zhang, MD, MHS, FASCO (@tiansterzhangmd.bsky) @TiansterZhang]

Today was a bittersweet day as I held my last clinic session @dukemedicine @DukeCancer. 12 yrs here - these are the halls where I gained my clinical acumen, grew into an oncologist, and developed some research skills. I am so sad and so grateful for every minute of these 12 yrs.

[Andrew Armstrong @AarmstrongDuke]

Thrilled to share our latest ARCHES analysis by risk/volume/prior therapy to provide valuable information to men with mHSPC. Great teamwork with @AzadOncology @DukeGUCancer @AstellasUS @pfizer https://t.co/FG08uTUVpb$